Table 1.
Compound | IC50 [µm] | EC50 [µm] | ||
---|---|---|---|---|
QscR | LasR | QscR | LasR | |
OdDHL | – | –[d] | 0.022[c] | 0.01[b] |
DDHL | – | – | 0.005[c] | 0.04[b] |
OOHL | – | 0.11[b] | 0.011[c] | –[d] |
1 | 0.030[c] | – | – | – |
2 | 0.13[c] | – | – | – |
3 | 0.16[c] | – | – | – |
4 | 0.18[c] | – | – | – |
5 | – | – | 0.056[c] | 0.01[b] |
6 | – | 0.25[b] | 0.006[c] | >200[b] |
Q4 | 0.56[e] | – | – | – |
Q5 | 0.11[e] | – | – | – |
Q9 | 0.011 | – | – | – |
Q10 | – | – | 1.1 | – |
Q12 | 0.14[e] | – | – | – |
Q13 | 0.22[e] | – | – | – |
R1 | 1.9[e] | – | – | >200 |
R4 | – | – | 2.0 | – |
R5 | – | – | 0.89 | – |
R6 | 0.057 | 1.0 | – | – |
S1 | – | – | – | – |
S2 | – | – | 0.10 | – |
S3 | – | – | 0.079 | >200 |
S6 | – | – | – | – |
S7 | 0.020[e] | 10 | 0.078 | – |
For strain and assay information, see the Experimental Section. Determined by testing AHLs over a range of concentrations (10−2–105 nm). All assays were performed in triplicate; italicized compounds are controls.
Values reported previously, see ref. [24].
Values reported previously, see ref. [26].
Not determined.
Antagonism dose–response curve up-turned at higher concentrations; see the Supporting Information.